Satellos Bioscience Inc. Common Stock (MSLE) News

Latest headlines that mention MSLE, newest first · each headline opens the original publisher

MSLE quote

Last price: $6.95
Day change: -7.21%
Next earnings: 2026-11-13

Quote & chart Expected move Insider trading IV rank history

MSLE headlines

latest coverage

Not much coverage yet. MSLE has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 5d ago

Satellos changes primary endpoint in DMD trial after FDA talks

General T3MSLE

Investing.com 1mo ago

Satellos completes enrollment for Duchenne trial, delays data

General T3MSLE

Investing.com 1mo ago

Satellos stock jumps after FDA clears FSHD trial for forazapadin

General T3MSLE

Seeking Alpha 2mo ago

Satellos Bioscience Inc. GAAP EPS of -$0.56

Earnings T2MSLE

Investing.com 5mo ago

Form 6K Satellos Bioscience Inc For: 1 June

General T3MSLE

Seeking Alpha 6mo ago

Satellos Bioscience GAAP EPS of -$0.53 misses by $0.01

Earnings T2MSLE

MSLE news alerts

Get an alert by email or push when a new headline mentions MSLE.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.